B. LYNNE PARSHALL - 26 Aug 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John O. Faurescu, attorney-in-fact for Ms. Parshall
Issuer symbol
CYTK
Transactions as of
26 Aug 2024
Net transactions value
-$178,250
Form type
4
Filing time
26 Aug 2024, 16:00:33 UTC
Previous filing
12 Aug 2024
Next filing
09 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $108,050 +5,000 +24% $21.61 25,600 26 Aug 2024 Direct
transaction CYTK Common Stock Sale $286,300 -5,000 -20% $57.26 20,600 26 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -5,000 -50% $0.000000 5,000 26 Aug 2024 Common Stock 5,000 $21.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant.